Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ADMA Biologics (ADMA – Research Report), Adaptimmune Therapeutics (ADAP – Research Report) and Bioxcel Therapeutics (BTAI – Research Report).
ADMA Biologics (ADMA)
In a report released today, Anthony Petrone from Mizuho Securities reiterated a Buy rating on ADMA Biologics, with a price target of $7.00. The company’s shares closed last Thursday at $3.75.
According to TipRanks.com, Petrone is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for ADMA Biologics with a $6.00 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Adaptimmune Therapeutics (ADAP)
In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Buy rating on Adaptimmune Therapeutics, with a price target of $9.00. The company’s shares closed last Thursday at $0.52, close to its 52-week low of $0.52.
According to TipRanks.com, Goldstein has 0 stars on 0-5 stars ranking scale with an average return of
Adaptimmune Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $4.25, representing a 672.0% upside. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock.
Bioxcel Therapeutics (BTAI)
In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Bioxcel Therapeutics, with a price target of $4.00. The company’s shares closed last Thursday at $4.63, close to its 52-week low of $2.23.
According to TipRanks.com, Suvannavejh ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bioxcel Therapeutics with a $9.67 average price target, representing an 115.8% upside. In a report issued on October 27, Goldman Sachs also maintained a Hold rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ADMA:
